bladder carcinoma
DESCRIPTION
Bladder Carcinoma. Dr. Abdelaty Shawky Dr. Gehan Mohamed. Learning objectives. 1- understand definition of bladder carcinoma 2- identify commonest age and sex incidence 3- Discuss risk factors for the development of bladder carcinoma. 4- List microscopic types of bladder carcinoma. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/1.jpg)
Bladder CarcinomaBladder Carcinoma
Dr. Abdelaty Shawky Dr. Gehan MohamedDr. Abdelaty Shawky Dr. Gehan Mohamed
![Page 2: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/2.jpg)
Learning objectives1- understand definition of bladder carcinoma2- identify commonest age and sex incidence3- Discuss risk factors for the development of bladder carcinoma.4- List microscopic types of bladder carcinoma.5- identify clinical presentation of these patients and what are investigations needed to determine the grade and stage of the tumor. 6- list complications and methods of treatment of bladder carcinoma.
2
![Page 3: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/3.jpg)
Bladder Carcinoma
• Definition: malignant tumor arising from the epithelial lining of the urinary bladder.
• (N.B normal epithelial lining of urinary bladder is transitional epithelium but it can change to squamous epithelium or columnar type under the effect of continuous irritation by inflammation, or stone formation)
3
![Page 4: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/4.jpg)
4
![Page 5: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/5.jpg)
Transitional epithelium (urothelium) lining the normal urinary Bladder.
5
![Page 6: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/6.jpg)
Epidemiology of Bladder Carcinoma• Carcinoma of the bladder is more common in
males than females, in industrialized than in developing nations, and in urban than in rural dwellers.
• The male to female ratio for transitional cell tumors is approximately 3:1.
• About 80% of patients are between the ages of 50 and 80 years.
6
![Page 7: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/7.jpg)
* Risk Factors for Bladder Cancer:
1. Cigarette smoking: is clearly the most important influence,
increasing the risk threefold to sevenfold, depending on the pack-
years and smoking habits. 50% to 80% of all bladder cancers
among men are associated with the use of cigarettes, cigars and
pipes.
2. Industrial exposure to naphthylamine as present in
aniline dye used in rubber industries. The cancers appear 15 to
40 years after the first exposure.
7
![Page 8: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/8.jpg)
3. Schistosoma haematobium: infections in areas where these are endemic (Egypt, Sudan) are an established risk. The ova are deposited in the bladder wall and incite a brisk chronic inflammatory response that induces progressive mucosal squamous metaplasia and dysplasia and, in some instances, neoplasia. Seventy per cent of the cancers are squamous, the remainder being urothelial cell carcinoma.
8
![Page 9: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/9.jpg)
4. Long-term use of analgesics.5. Heavy long-term exposure to cyclophosphamide, an immunosuppressive agent, induces, as noted, hemorrhagic cystitis and increases the risk of bladder cancer.6. Prior exposure of the bladder to radiation: often performed for other pelvic malignancies, increases the risk of urothelial carcinoma. In this setting, bladder cancer occurs many years after the radiation.
9
![Page 10: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/10.jpg)
7. Bladder stones: cause chronic irritation to the mucosa so increase risk for squamous cell metaplasia then cancer.
10
![Page 11: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/11.jpg)
*Histologic types of bladder carcinoma:
1. Transitional cell carcinoma.
– TCC in situ.
– Papillary (superficial) TCC carcinoma.
– Invasive TCC .
2. Squamous cell carcinoma:
- On top of squamous metaplasia.
3. Adenocarcinoma.11
![Page 12: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/12.jpg)
12
![Page 13: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/13.jpg)
Papillary carcinomaPapillary carcinoma
13
![Page 14: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/14.jpg)
Fungating carcinoma of UB
14
![Page 15: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/15.jpg)
TCC in situ
15
![Page 16: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/16.jpg)
Superficial papillary TCC
16
![Page 17: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/17.jpg)
Papillary transitional cell
carcinoma
17
![Page 18: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/18.jpg)
Papillary Transitional
cell carcinoma
18
![Page 19: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/19.jpg)
Infiltrating transitional cell carcinoma
19
![Page 20: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/20.jpg)
Squamous metaplasia in bladder
20
![Page 21: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/21.jpg)
Squamous cell carcinoma showing keratinized nests of squamous epithelium
21
![Page 22: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/22.jpg)
Adenocarcinoma : tumor cells form glands with malignant criteria , and deeply infiltrating
22
![Page 23: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/23.jpg)
* Clinical Manifestations of Bladder CA
1. Hematuria (80-90%): Generally painless and may be gross
or microscopic hematuria.
2. Pain: often reflects tumor location
– Lower abdominal pain – Bladder mass
– Rectal discomfort & perineal pain – Invasion of prostate or
pelvis.
– Flank pain - Obstruction of ureters
23
![Page 24: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/24.jpg)
3. Other urinary Symptoms:
– Frequency, urgency, nocturia due to irritation of the
mucosa or due to decrease bladder capacity.
24
![Page 25: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/25.jpg)
* Investigations for Bladder Cancer:
1. Urinary Cytology: to detect any desquamated
malignant cells.
2. Cystoscopy: regardless of cytology results.
3. TURB (Transurethral resection of bladder
tumor) for all visible tumors to determine
histology & depth of invasion
25
![Page 26: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/26.jpg)
4. Imaging:
A. Ultrasonography
B. CT, or MRI - Can determine the extent of tumor
spread (e.g. into perivsesical fat, prostate or
vagina, LNs)
C. CT chest / abdomen, MRI, radionuclide imaging of
skeleton to assess for distant metastasis.
26
![Page 27: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/27.jpg)
* Grading of transitional cell carcinoma:
1. Low grade TCC: - The tumor cells are less pleomorphic, slightly
similar to the cell of origin, few mitosis, so have better prognosis.
2. High grade TCC: - The cells highly pleomorphic, have more
mitosis. - worse prognosis because it have aggressive
behavior, more infiltrative27
![Page 28: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/28.jpg)
*TNM staging for bladder carcinoma:• T: T: is tumor size.
• N: N: express lymph node affection by the tumor so: - N0 no affection to lymph nodes. - N+ the lymph nodes are infiltrated by the tumor
• M:M: express distant metastasis so: - M0 no distant metastasis. - M+ there is distant metastasis.
28
![Page 29: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/29.jpg)
T: Tumor size.
• pT 0: pT 0: carcinoma in situ.
• pT I: pT I: the tumor infiltrates the lamina propria.
• pT II: pT II: the tumor infiltrates the musculosa
propria.
• pT3: pT3: the tumor infiltrates perivesical fat.
• pT4: pT4: distant spread.
29
![Page 30: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/30.jpg)
30
![Page 31: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/31.jpg)
* Complications of urinary bladder carcinoma:
1. Bleeding.2. Obstruction: specially if the tumor grow near the urethral openings of the bladder lead to obstructive uropathy in the form of hydroureter, hydronephrosis 3. Stone formation: secondary to the obstruction and infection.4. Fistual formation: fistula is an abnormal channel that connects the urinary bladder with another structure within the abdomen.
31
![Page 32: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/32.jpg)
6. Spread of the malignant tumor either by : a. Direct spread to surrounding structures b. Hematogenous spread to distant organs. c. Lymphatic spread.
32
![Page 33: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/33.jpg)
Treatment & Prognosis of Bladder Treatment & Prognosis of Bladder carcinomacarcinoma
33
![Page 34: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/34.jpg)
I. Superficial non-muscle invasive TCC: I. Superficial non-muscle invasive TCC:
•Requires at least complete endoscopic resection +/-
intravesical therapy using Bacillus Calmette-Guérin (BCG)
vaccine which act through stimulation of the immune
system in such a way that the immune system begins to
target and destroy any remaining cancer cells.
•Of good prognosis.
34
![Page 35: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/35.jpg)
II. Muscle-Invasive TCC:II. Muscle-Invasive TCC:
• Generally radical cystectomy & pelvic lymphadenectomy.
• Of bad prognosis.– Removal of bladder & pelvic LNs.– + Removal of prostate, seminal vesicles, & proximal
urethra in males. Generally impotence.– + Removal of urethra, uterus, fallopian tubes, ovaries,
anterior vaginal wall, & surrounding fascia in females.
35
![Page 36: Bladder Carcinoma](https://reader035.vdocuments.us/reader035/viewer/2022070411/5681474c550346895db48fce/html5/thumbnails/36.jpg)
ThanksThanks
36